![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Dolutegravir, Boceprevir, Telaprevir PK: The effect of Boceprevir and Telaprevir on Dolutegravir Pharmacokinetics, in Healthy Adult Subjects
|
|
|
Reported by Jules Levin
14th Clinical Pharmacology in HIV and HCV Workshop
April 22-24 2013 Amsterdam
ClinPharmWk: No Clinically Significant Interactions Between Boceprevir or Telaprevir and Dolutegravir - written by Mark Mascolini - (04/29/13)
14th Intrntnl Wrkshp Clinical Pharm HIV Therapy Clinical Pharmacology at the 14th Workshop on Clinical Pharmacology of HIV Therapy and HCV - Courtney V. Fletcher, Pharm.D. Dean and Professor College of Pharmacy University of Nebraska Medical Center - (05/20/13)
Mark Johnson, Julir Borland, Shuguang Chen, Paul Savina, Brian Wynne, Stephen Piscatelli, GlaxoSmithKline
![Pharm1.gif](../images/052613/052613-9/Pharm1.gif)
![Pharm2.gif](../images/052613/052613-9/Pharm2.gif)
![Pharm3.gif](../images/052613/052613-9/Pharm3.gif)
![Pharm4.gif](../images/052613/052613-9/Pharm4.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|